Branko Dujovic | Dermatoncology | Innovative Research Award

Innovative Research Award

Researcher Information
Affiliation Military Medical Academy
Country Serbia
Scopus ID 58245030500
Documents 6
Citations 21
h-index 2
Subject Area Dermatoncology
Event Global Diseases Research Awards
ORCID 0009-0009-1497-5777

Branko Dujovic of the Military Medical Academy, Serbia, is recognized for his contributions to medical research, with a particular focus on dermatoncology. The Innovative Research Award highlights his scholarly excellence, scientific integrity, and meaningful impact on advancing clinical science. Through his published research, interdisciplinary collaboration, and commitment to evidence-based medical investigation, he has built a strong academic profile. His work emphasizes improvements in disease diagnosis, evaluation of treatment strategies, and enhancement of patient-centered healthcare outcomes, reflecting a consistent dedication to advancing knowledge and strengthening modern clinical practice in oncology and dermatology-related research.

Abstract

Branko Dujovic is a researcher affiliated with the Military Medical Academy in Serbia whose scholarly activities contribute to the field of dermatoncology. Through peer-reviewed publications, clinical investigations, and collaborative research efforts, he has supported the advancement of scientific understanding related to skin cancer and associated diseases. His academic record, including indexed publications, citations, and international researcher identifiers, demonstrates engagement with contemporary medical science. The Innovative Research Award acknowledges researchers whose work promotes scientific progress, encourages evidence-based practice, and contributes to improving healthcare knowledge through responsible and impactful research activities.[1]

Keywords

Dermatoncology, Clinical Research, Medical Science, Skin Cancer Research, Academic Excellence, Innovative Research Award, Healthcare Innovation, Disease Investigation, Scientific Publications, Global Diseases Research Awards.

Introduction

Dermatoncology represents a specialized area of medicine focused on understanding, diagnosing, and managing skin-related cancers. Researchers working within this discipline contribute valuable evidence supporting clinical decision-making and patient care improvements. Branko Dujovic has participated in research activities that align with these objectives and support ongoing scientific advancement within the medical community.[1]

Research Profile

Affiliated with the Military Medical Academy, Branko Dujovic maintains an academic profile indexed within international scholarly databases. His publication record includes research outputs relevant to dermatoncology and related medical disciplines. The available metrics indicate active participation in scientific communication and engagement with peer-reviewed research environments.[4]

Research Contributions

The research contributions of Branko Dujovic are associated with clinical and scientific investigations addressing disease mechanisms, patient outcomes, and healthcare practices. His studies support the broader body of medical knowledge by providing data-driven insights that may assist clinicians, researchers, and healthcare institutions in understanding dermatological oncology challenges.[2]

Publications

The researcher has produced six indexed documents that collectively contribute to scholarly discussion within his field. These publications demonstrate participation in scientific dissemination and provide evidence of sustained academic activity. Published work remains an important indicator of research productivity, professional collaboration, and contribution to medical literature.

Research Impact

Citation metrics indicate that the researcher’s publications have been referenced by other scholars, reflecting engagement within the scientific community. While quantitative indicators provide only one measure of influence, citations and indexing demonstrate the visibility of research outputs and their relevance to ongoing academic discussions.[1]

Award Suitability

Branko Dujovic demonstrates characteristics associated with the objectives of the Innovative Research Award, including scholarly productivity, scientific engagement, and commitment to advancing medical knowledge. His documented research activities, institutional affiliation, and contributions to dermatoncology support consideration for recognition within the Global Diseases Research Awards program.[3]

Conclusion

The academic profile of Branko Dujovic reflects participation in meaningful scientific research within dermatoncology. Through publications, citation impact, and professional engagement, he contributes to the advancement of healthcare knowledge. Recognition through the Innovative Research Award highlights the value of continued research efforts that support evidence-based medicine and scientific progress.[1]

References

  1. Elsevier. (n.d.). Scopus author details: Branko Dujovic, Author ID 58245030500. Scopus
    .https://www.scopus.com/authid/detail.uri?authorId=58245030500
  2. ORCID. (n.d.). Researcher profile and scholarly identifier for Branko Dujovic
    .
    https://orcid.org/0009-0009-1497-5777
  3. Global Diseases Research Awards. (n.d.). Innovative Research Award and recognition framework.
    https://globaldiseases.org/
  4. Dujovic, B., Popovic, A., Jalovcic Suljevic, A., Cikota-Aleksic, B., Balic, M., Salatic, I., Pavlica, J., Schnecko, P., Mesti, T., Terzo, M., Bicakcic Filipovic, E., & Kandolf, L. (2026). Prognostic significance of inflammatory biomarkers in first-line immunotherapy for metastatic melanoma: Multicentric study (Version 1). Preprints.org.
    https://doi.org/10.20944/preprints202604.1631.v1
  5. Torres-Zurita, A., Vázquez-Montero, L., Gallego-López, L., Mediano-Rambla, M. D., & de la Cruz-Merino, L. (2023). Sarcoidosis-like reaction induced by immune checkpoint inhibitor in a patient with hepatocellular carcinoma: A case report. Frontiers in Immunology, 14, 1150128.
    https://doi.org/10.3389/fimmu.2023.1150128

Elisabeth Spenard | Gynecologic Oncology | Best Researcher Award

Assist. Prof. Dr. Elisabeth Spenard | Gynecologic Oncology | Best Researcher Award 

MD | Laval University | Canada

Dr. Elisabeth Spénard, MD, MSc, FRCSC, is a highly accomplished Gynecologic Oncologist and Clinical Teaching Associate at Université Laval, where she also serves as Academic Director, Co-Research Director, and Quality Improvement Lead in the Division of Gynecologic Oncology. She holds active staff appointments in Gynecologic Oncology at Hôtel-Dieu de Québec and has been an Assistant Professor at the Institute of Health Policy, Management and Evaluation (IHPME), University of Toronto, where she supervises Master’s students in the Quality Improvement and Patient Safety (QIPS) program. Dr. Spénard completed her residency in Obstetrics and Gynecology at the University of Montreal, a fellowship in Gynecologic Oncology at the University of Toronto, and a Master of Science in QIPS, equipping her with strong expertise in patient-centered care, surgical oncology, and clinical research. Her professional journey is marked by leadership roles in national and institutional committees, including co-leading the ERAS Gynecology Oncology Committee with Quebec’s Ministry of Health and serving as a reviewer and judge for ovarian cancer research awards. She has earned multiple awards, such as the Bruce Galloway Trainee Award, and distinctions for best oral and poster presentations from leading Canadian gynecologic oncology associations. Her research is focused on hereditary cancers, surgical innovation, and quality improvement, supported by competitive grants such as the Surgical Oncology Innovations Grant and Canadian Blood Services Accelerator Grant. With an expanding academic footprint, Dr. Spénard has authored 6  publications, cited 35 times, with an h-index of 3, underscoring her growing contributions to advancing gynecologic oncology research and education

Profile: Scopus

Featured Publication

1. Spénard, E., Lin, Y., Covens, A., Gien, L. T., Vicus, D., et al. (2025). Optimizing the screening and management of preoperative anemia prior to gynecologic oncology surgery (OPRA1): A quality improvement initiative. Gynecologic Oncology. Advance online publication.